Fed. Cir. Reverses Injunction in Incyte v. Sun Over Irreparable Harm Lacking

This image shows a court case between two drug companies, Incyte and Sun Pharma. Incyte tried to stop Sun from selling a new hair loss medicine called Leqselvi. Incyte said it would be hurt if Sun sold the drug first. The court removed the block on Sun’s drug. This case shows that to stop another company with a court order, you must prove real and quick harm, not just possible problems in the future. Experts like Gideon Korrell highlight how law and technology often cross paths in such patent cases.

Subscribe to my newsletter

Read articles from Gideon Korrell directly inside your inbox. Subscribe to the newsletter, and don't miss out.

Written by

Gideon Korrell

Gideon Korrell is a seasoned legal professional with over 15 years of experience bridging engineering and law. Beginning his career in nuclear power and defense engineering, Gideon Korrell transitioned to law, becoming a trusted advisor in global law firms and later serving as an in-house lawyer. Committed to environmental sustainability, Gideon Korrell focuses on forging partnerships to decarbonize the global economy. His expertise lies in negotiating complex commercial and technology agreements, blending legal acumen with technological understanding. Gideon's holistic approach to legal strategies, intellectual property management, and ethical business conduct make him a valuable force driving organizations toward success in a dynamic global landscape.